PegBio Co., Ltd. (HKG:2565)
Hong Kong
· Delayed Price · Currency is HKD 10.94
+0.36 (3.40%)
Last updated: May 29, 2025
PegBio Statistics
Total Valuation
PegBio has a market cap or net worth of HKD 3.94 billion. The enterprise value is 3.86 billion.
| Market Cap | 3.94B |
| Enterprise Value | 3.86B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
PegBio has 385.96 million shares outstanding.
| Current Share Class | 279.16M |
| Shares Outstanding | 385.96M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 24.53% |
| Owned by Institutions (%) | 21.88% |
| Float | 86.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 64.37 |
| P/TBV Ratio | 72.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.80 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -19.66 |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 1.77.
| Current Ratio | 1.21 |
| Quick Ratio | 1.18 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.55 |
| Interest Coverage | -115.08 |
Financial Efficiency
Return on equity (ROE) is -224.15% and return on invested capital (ROIC) is -84.94%.
| Return on Equity (ROE) | -224.15% |
| Return on Assets (ROA) | -61.30% |
| Return on Invested Capital (ROIC) | -84.94% |
| Return on Capital Employed (ROCE) | -473.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -5.69M |
| Employee Count | 53 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 4,186,725 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -306.05M |
| Pretax Income | -301.53M |
| Net Income | -301.33M |
| EBITDA | -305.17M |
| EBIT | -306.05M |
| Earnings Per Share (EPS) | -0.82 |
Balance Sheet
The company has 193.73 million in cash and 108.01 million in debt, giving a net cash position of 85.72 million or 0.22 per share.
| Cash & Cash Equivalents | 193.73M |
| Total Debt | 108.01M |
| Net Cash | 85.72M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 61.16M |
| Book Value Per Share | 0.15 |
| Working Capital | 34.72M |
Cash Flow
In the last 12 months, operating cash flow was -195.21 million and capital expenditures -932,215, giving a free cash flow of -196.15 million.
| Operating Cash Flow | -195.21M |
| Capital Expenditures | -932,215 |
| Free Cash Flow | -196.15M |
| FCF Per Share | -0.51 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PegBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -7.65% |
| FCF Yield | -4.98% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |